Advertisement

Topics

Latest "The Word & Brown Companies" News Stories

00:23 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "The Word & Brown Companies" found in our extensive news archives from over 250 global news sources.

More Information about The Word & Brown Companies on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The Word & Brown Companies for you to read. Along with our medical data and news we also list The Word & Brown Companies Clinical Trials, which are updated daily. BioPortfolio also has a large database of The Word & Brown Companies Companies for you to search.

Showing "Word Brown Companies" News Articles 1–25 of 6,100+

Wednesday 20th February 2019

Chemed Reports Fourth-Quarter 2018 Results

Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2018, versus the com...


Study Demonstrates Cook Biotech's OASIS® Wound Matrix Has Higher Rates of Healing in Pressure Ulcers Than Standard of Care

A recently published multi-center, randomized, controlled trial (RCT) demonstrated higher rates of healing when using OASIS® Wound Matrix with standard of care (SOC) for the treatment of full-thickness Stage III or Stage IV pressure ulcers than when using SOC alone.1 Pressure ulcers are open wounds caused by pressure. They often occur when an ind...

AMPLEXOR Life Sciences Presents at Pharma Packaging and Labeling, East Coast

AMPLEXOR Life Sciences: MEDIA ADVISORY:   From addressing the evolving regulations to exploring the potential of disruptive technologies that help manage your packaging and labeling requirements, AMPLEXOR’s Kathleen O’Brien ...


Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference

DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference in New York. Geoff Martha, executive vice president and president of the Restorative Therapies Group (RTG) of Medtronic, will make a brief presentation and answer questions on the company, b...

KultureCity Named To Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019

KultureCity has earned the standing of number 4 on the 2019 Most Innovative Companies List in the Live Events category. BIRMINGHAM, Ala. (PRWEB) February 20, 2019 The list honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world. Half of the companies on this year’s MIC 50 list are appearing for the fi...

Putting Their Money Where Their Mouth Is: Growing List of All-Star Athletes Invest in Beyond Meat®

Kyrie Irving, Chris Paul, DeAndre Hopkins and others are backing the brand after experiencing first-hand the health and performance benefits of plant-based meat Aligning with the brand’s rallying cry to Go Beyond, the growing roster of investors and ambassadors is comprised of individuals who shatter the status quo to purs...

Bausch Health Companies, Inc. (BHC) CEO Joseph Papa on Q4 2018 Results - Earnings Call Transcript

Instagram Influencers Promote Prescription Drugs; FDA's Continuing Monitoring

The FDS has warned pharmaceutical companies in the past about their use of paid surrogates on social media sites like Instagram to promote their products (see: Pharmaceutical Companies Continue to Experiment with Social Media; FDA Issues Warning Letter to Drug Company about Use of Instagram; GlaxoSmithKline Mines Social Media for...

What Role Should Big Social Media Companies Play In Public Health Issues?

The recent attempts from social media companies to limit antivaccination posts highlights both the struggles of trying to monitor such content and the impact the tech leaders can have on the national conversation. In other health technology news: the limits of artificial intelligence, exposure of personal health information, and a mental health app that can help with loneliness.

Teva Barred From Agreeing ‘No-Authorized Generics’ Deals Under Reverse-Payment FTC Settlement

Modifying terms to a 2015 consent decree involving its Cephalon unit, Teva has reached a global settlement agreement with the...   

Fast Company Names HeartFlow One of the World’s Most Innovative Companies

HeartFlow Earns a Top Position in Artificial Intelligence for 2019 HeartFlow, Inc., a medical technology company uniquely positioned at the intersection of advanced artificial intelligence (AI) capabilities and healthcare, today announced it has been named to Fast Company’s prestigious annual list of the

Milk Stork Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2019

Milk Stork, the first-ever breast milk shipping company, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019. The list honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world. Milk Stork w...

Medigate Named To Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019

Medigate has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019. The list honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world. Half of the companies on this year’s MIC 50 list are appea...

Recursion Named to Fast Company’s Annual List of the World’s Most Innovative Companies

Recursion, a clinical-stage biotechnology company that combines artificial intelligence (AI), experimental biology, and automation to discover and develop drugs at scale, has been named to Fast Company’s annual list of the World’s Most Innovative Companies for 2019. The list honors the businesses making the most profound impact on both industry ...

Fresenius Medical Care announces retirement of Chief Financial Officer Michael Brosnan

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous 20.02.2019 / 10:29 The issuer is solely responsible for the content of this announcement. Fresenius Medical Care, the world's largest provider of dialysis products and services, today announced that CFO Michael Brosnan plans to retire from the Company after his successor has been identified and transitioned int...

Bausch Health Companies Inc. 2018 Q4 - Results - Earnings Call Slides

CO.DON AG attended BIO CEO & Investor Conference in New York

DGAP-News: CO.DON AG / Key word(s): Conference 20.02.2019 / 09:59 The issuer is solely responsible for the content of this announcement. CO.DON AG attended BIO CEO & Investor Conference in New York Berlin / Teltow, 20 February 2019 - On 10 and 11 February 2019 the 21st BIO CEO & Investor Conference took place in New York. The annual BIO CEO & Investor Conference is one of t...

Companies raised US$5.4bn globally so far in 2019 down by 78% from the same period a year ago marking the lowest year-to-date value in three years according to Dealogic @SCMPNews https://buff.ly/2Nik27i 

Companies raised US$5.4bn globally so far in 2019 down by 78% from the same period a year ago marking the lowest year-to-date value in three years according to Dealogic @SCMPNews https://buff.ly/2Nik27i 

Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care resolves share repurchase program with an aggregate volume of up to one billion Euros

Fresenius Medical Care AG & Co. KGaA / Key word(s): Share Buyback Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care resolves share repurchase program with an aggregate volume of up to one billion Euros 20-Feb-2019 / 07:01 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The i...

Medartis announces preliminary key figures for the 2018 financial year

Medartis Holding AG / Key word(s): Preliminary Results 20-Feb-2019 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 18 KR The issuer is solely responsible for the content of this announcement. Medartis Holding AG Hochbergerstrasse 60E CH-4057 Basel PRESS RELEASE Medartis announces preliminary key figures for the 2018 financial year Basel, Switzerland, 20 February...

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

EQS Group-News: ADC Therapeutics SA / Key word(s): Study 20.02.2019 / 07:00 ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma   Combination trial to evaluate safety and anti-tumor activity of agents that target B-cell cancers &nbs...

Two Pharma Companies File Chapter 11 Bankruptcy http://dlvr.it/QzGzcj pic.twitter.com/OrRu00u6Fg

Two Pharma Companies File Chapter 11 Bankruptcy http://dlvr.it/QzGzcj  pic.twitter.com/OrRu00u6Fg

Tuesday 19th February 2019

Fast Company Names T2Biosystems One of the World’s Most Innovative Companies – For Battling Sepsis in Hours not Days

LEXINGTON, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, was recognized today by Fast Company among the top 10 of the world’s most innovative companies in the biotech category. The complete list of winners, which also included Foundation Medicine, Alnylam and

Fast Company Selects Biotech Companies as Part of Its 2019 List of Innovative Companies

For its 2019 list of the top 50 most innovative companies, Fast Company selected 10 from the biotech industry that are having a significant impact on the treatment of patients. The first five are highlighted.

Metabolic reprogramming in cancer

Metabolomics has demonstrated significant potential in early diagnosis of diseases, in therapy monitoring and in understanding the pathogenesis of different diseases, according to research firm Technavio. “Researchers are investigating metabolome coverage in human breast cancer tissues to undertake metabolic profiling. The derived metabolomic results can be used to classify breast cancer based ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks